This week in charts: Moderna’s massive stock run

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 16 Oct, 13:15 UTC

The latest installment in BioPharma Dive’s data visualization-focused series includes a look at Moderna’s meteoric rise in 2026 and a sudden deal surge from Roche.